|
1. BIOLOGIE
|
|
|
|
3.3 PRÉVENTION - VACCINS
|
|
|
|
4. DÉPISTAGE, DIAGNOSTIC ET PRONOSTIC
|
|
|
Some types of prostate cancer may not be as aggressive as originally thought [UCLA]
|
|
|
|
|
|
Researchers at the UCLA Jonsson Comprehensive Cancer Center analyzed gene-expression patterns in the most aggressive prostate cancer grade group — known as Gleason grade group 5 — and found that this grade of cancer can actually be subdivided into four subtypes with distinct differences. The findings may affect how people are treated for the disease.
|
|
|
|
|
|
|
4.2 DÉP., DIAG. & PRONO. - GÉNOME
|
|
|
|
|
5. TRAITEMENTS
|
|
|
|
5.1 TRAITEMENTS - PRÉ-CLINIQUE
|
|
|
|
5.12.11 IMMUNOTHÉRAPIES - PRÉ-CLINIQUE
|
|
|
|
|
5.12.4 IMMUNOTHÉRAPIES - ESSAIS
|
|
|
|
5.12.5 IMMUNOTHÉRAPIES - PHARMA
|
|
|
|
5.12.6 IMMUNOTHÉRAPIES - AMM
|
|
|
|
5.2.1 PHARMA - PARTENARIATS
|
|
|
|
|
|
5.2.6 PHARMA - BIOTECH
|
|
|
|
5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)
|
|
|
|
5.5 ASCO
|
|
|
|
5.5.15 ASCO (BIOPSIES LIQUIDES)
|
|
|
|
5.9.3 EHA
|
|
|
|
6.15 LUTTE CONTRE LES CANCERS - COVID-19
|
|
|